Early Guillain-Barré Syndrome associated with acute dengue fever

Journal of Clinical Virology

Volumn 77, Issue , 2016, Pages 29-31

  Simon, O ^a   Billot, S ^a   Guyon, D ^a   Daures, M ^b   Descloux, E ^a   Gourinat, A C ^c   Molko, N ^a   Dupont Rouzeyrol, M ^c  

^a Noumea Territorial Hospital   (New Caledonia)

^b New Caledonia University   (New Caledonia)

^c Institut Pasteur de Nouvelle Caledonie Noumea   (New Caledonia)

Author keywords

Acute; Dengue; Guillain Barr Syndrome; Infectious disease; Neurology

Indexed keywords

ANTINUCLEAR ANTIBODY; CREATININE; ELECTROLYTE; GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN; PHOSPHOTRANSFERASE; VIRUS RNA;

ADULT; AGED; ARTHRALGIA; ARTICLE; AUTOIMMUNITY; BLOOD ANALYSIS; CASE REPORT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CONCURRENT INFECTION; CREATININE BLOOD LEVEL; DENGUE; DENGUE VIRUS 1; DISEASE ASSOCIATION; DYSPHAGIA; ELECTROLYTE BLOOD LEVEL; ELECTRONEUROGRAPHY; ELECTROPHORESIS; FACIAL NERVE PARALYSIS; FEMALE; FEVER; GAIT DISORDER; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; LATENT PERIOD; LYMPHOCYTOPENIA; MALE; MIDDLE AGED; MOTOR NERVE CONDUCTION; MYALGIA; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUADRIPLEGIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; THROMBOCYTOPENIA; VIRUS LOAD; COMPLICATION; DENGUE VIRUS; GENETICS; GUILLAIN-BARRE SYNDROME; POLYMERASE CHAIN REACTION;

AGED; DENGUE; DENGUE VIRUS; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 84960467269     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2016.01.016     Document Type: Article

References (13)

1. Dupont-Rouzeyrol M., Aubry M., Connor O.O., Roche C., Gourinat A.C., Guigon A., Pyke A., Grangeon J.P., Nilles E., Chanteau S., Aaskov J., Cao-Lormeau V.M. Epidemiological and molecular features of dengue virus type-1 in New Caledoni, South Pacific, 2001-2013. Virol. J. 2014, 11:61.
2. Hughes R.A., Cornblath D.R. Guillain-Barre syndrome. Lancet 2005, 366:1653-1666.
3. Halstead S.B. Dengue. Lancet 2007, 370:1644-1652.
4. World Health Organization, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control (2009). Available from: http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf.
5. Carod-Artal F.J., Wichmann O., Farrar J., Gascon J. Neurological complications of dengue virus infection. Lancet Neurol. 2013, 12:906-919.
6. Oehler E., Le Henaff O., Ghawche F. Neurological manifestations of dengue. Presse Med. 2012, 41:e547-552.
7. Soares C.N., Cabral-Castro M., Oliveira C., Faria L.C., Peralta J.M., Freitas M.R., Puccioni-Sohler M. Oligosymptomatic dengue infection: a potential cause of Guillain Barre syndrome. Arq. Neuropsiquiatr. 2008, 66:234-237.
8. Sharma C.M., Kumawat B.L., Ralot T., Tripathi G., Dixit S. Guillain-Barre syndrome occurring during dengue fever. J. Indian Med. Assoc. 2011, 109:675-682.
9. Gaultier C., Angibaud G., Laille M., Lacassin F. Probable Miller Fisher syndrome during dengue fever type 2. Revue Neurologique (Paris) 2000, 156:169-171.
10. Guzman M.G., Kouri G., Valdes L., Bravo J., Alvarez M., Vazques S., Delgado I., Halstead S.B. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am. J. Epidemiol. 2000, 152:793-799. Discussion 804.
11. Domingues R.B., Kuster G.W., Onuki-Castro F.L., Souza V.A., Levi J.E., Pannuti C.S. Involvement of the central nervous system in patients with dengue virus infection. J. Neurol. Sci. 2008, 267:36-40.
12. Drescher K.M., Tracy S.M. Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination. Virology 2007, 359:233-242.
13. Sloan D.J., Nicolson A., Miller A.R., Beeching N.J., Beadsworth M.B. Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report. J. Med. Case Rep. 2008, 2:370.